Xvivo Perfusion AB (publ) (FRA:3XV)

Market Cap	673.35M -48.2%
Revenue (ttm)	75.05M -1.2%
Net Income	2.33M -85.4%
EPS	0.07 -85.3%
Shares Out	n/a
PE Ratio	289.60
Forward PE	61.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45
Average Volume	15
Open	20.84
Previous Close	20.96
Day's Range	20.84 - 21.92
52-Week Range	14.45 - 42.35
Beta	n/a
RSI	70.59
Earnings Date	Jan 27, 2026

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1998
• Employees: 198
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 3XV

Financial Performance

In 2025, Xvivo Perfusion AB's revenue was 812.17 million, a decrease of -1.25% compared to the previous year's 822.42 million. Earnings were 25.16 million, a decrease of -85.39%.

Financial numbers in SEK